1. Home
  2. SVM vs SLNO Comparison

SVM vs SLNO Comparison

Compare SVM & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SVM

Silvercorp Metals Inc.

HOLD

Current Price

$11.45

Market Cap

2.0B

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$39.79

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SVM
SLNO
Founded
N/A
1999
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
SVM
SLNO
Price
$11.45
$39.79
Analyst Decision
Hold
Strong Buy
Analyst Count
1
10
Target Price
$10.50
$112.70
AVG Volume (30 Days)
8.3M
1.5M
Earning Date
02-09-2026
02-26-2026
Dividend Yield
0.23%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$365,889,000.00
$98,675,000.00
Revenue This Year
$22.28
N/A
Revenue Next Year
$32.53
$159.08
P/E Ratio
N/A
N/A
Revenue Growth
37.31
N/A
52 Week Low
$3.15
$37.95
52 Week High
$14.00
$90.32

Technical Indicators

Market Signals
Indicator
SVM
SLNO
Relative Strength Index (RSI) 57.29 40.84
Support Level $9.56 $39.23
Resistance Level $11.25 $41.84
Average True Range (ATR) 0.84 2.02
MACD -0.16 0.06
Stochastic Oscillator 42.45 21.76

Price Performance

Historical Comparison
SVM
SLNO

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: